|
PDE7A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.78340050797033E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.26667598421682E-12 |
| Normal-vs-Stage2 |
4.91769958088639E-11 |
| Normal-vs-Stage3 |
3.30450000696203E-09 |
| Normal-vs-Stage4 |
5.93880500332489E-11 |
| Stage1-vs-Stage2 |
6.361600E-03 |
| Stage1-vs-Stage3 |
4.112200E-01 |
| Stage1-vs-Stage4 |
1.554070E-02 |
| Stage2-vs-Stage3 |
4.186200E-02 |
| Stage2-vs-Stage4 |
4.359400E-01 |
| Stage3-vs-Stage4 |
1.785820E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.36819999774218E-09 |
| Normal-vs-AfricanAmerican |
1.240670E-04 |
| Normal-vs-Asian |
1.75906999999587E-05 |
| Caucasian-vs-AfricanAmerican |
6.878800E-01 |
| Caucasian-vs-Asian |
3.271600E-01 |
| AfricanAmerican-vs-Asian |
7.830800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.58480006895445E-10 |
| Normal-vs-Female |
1.72084568816899E-12 |
| Male-vs-Female |
1.846810E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.22850002287822E-09 |
| Normal-vs-Age(41-60Yrs) |
7.34312610717325E-12 |
| Normal-vs-Age(61-80Yrs) |
3.42009753850903E-11 |
| Normal-vs-Age(81-100Yrs) |
5.979000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.997200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.338770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.859600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.316970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.878200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.020200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.091500E-02 |
| Classical-VS-Follicular |
4.572700E-04 |
| Classical-VS-Other |
1.192360E-01 |
| Classical-VS-Normal |
4.6236000028621E-08 |
| Tall-VS-Follicular |
2.960800E-01 |
| Tall-VS-Other |
2.794400E-01 |
| Tall-VS-Normal |
1.0407000039514E-08 |
| Follicular-VS-Other |
5.961200E-01 |
| Follicular-VS-Normal |
3.15680814821917E-12 |
| Other-VS-Normal |
1.07459999998394E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.81992265280951E-13 |
| Normal-vs-N1 |
4.30549995655838E-09 |
| N0-vs-N1 |
9.021600E-01 |
|
|
